Cyclic Hematopoiesis

MONDO:0008090 Pathograph 19 Show in embeddings browser congenital neutropenia

An autosomal dominant disorder of granulopoiesis in which the absolute neutrophil count oscillates on a regular cycle of roughly 21 days, falling to severely neutropenic levels and recovering to near normal. Most cases carry a heterozygous ELANE mutation. The prevailing model is that mutant neutrophil elastase misfolds, provokes endoplasmic reticulum stress and an unfolded protein response in granulocytic progenitors, and kills them; the oscillation arises because progenitor depletion drives compensatory G-CSF-stimulated proliferation, which then repopulates the compartment until the unfolded protein response overtakes it again. Clinically the disease is a rhythm of fever, mouth ulceration and infection at each nadir, with good health in between. Unlike severe congenital neutropenia, which shares the same gene, it carries no recognised risk of leukaemic transformation.

Ask OpenScientist

Ask a research question about Cyclic Hematopoiesis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
5
Pathophys.
8
Phenotypes
19
Pathograph
1
Genes
3
Medical Actions
2
Models
10
References
👪

Inheritance

1
Autosomal dominant HP:0000006
Autosomal dominant, occurring both as inherited and as sporadic disease. The kindred described by Newburger and colleagues also demonstrates paternal gonadal mosaicism as a mechanism of recurrence in apparently sporadic families.
Autosomal dominant inheritance
Show evidence (4 references)
PMID:11957190 SUPPORT Human Clinical
"Recent genetic, molecular, and cellular studies have shown that autosomal-dominant cyclic neutropenia and sporadic cases of this disease are due to a mutation in the gene for neutrophil elastase (ELA2), located at 19p13.3."
States the autosomal dominant inheritance and the existence of sporadic cases.
PMID:20582973 SUPPORT Human Clinical
"The mutant allele was detected in the donor's spermatozoa, representing 18% of the ELANE gene pool, but not in DNA from his lymphocytes, neutrophils, or buccal mucosa, indicating gonadal mosaicism."
Documents gonadal mosaicism, which is relevant to recurrence risk counselling in families with no detectable parental mutation.
PMID:20301705 SUPPORT Human Clinical
"One parent of a proband is usually affected. De novo pathogenic variants have been identified; their frequency is unknown."
Gives the transmission pattern and records that de novo variants occur without a known rate, which is the counselling-relevant qualifier alongside the mosaicism finding.
+ 1 more reference
⚙

Pathophysiology

5
ELANE Mutation and Neutrophil Elastase Misfolding
The initiating lesion. A heterozygous mutation in ELANE yields a neutrophil elastase that misfolds. Elastase is synthesised in neutrophil precursors early in primary granule formation, which is why the consequences fall on the granulocytic lineage specifically rather than on cells generally.
promyelocyte CL:0000836 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves promyelocyte (CL:0000836). CL:0000836 is a cell type from the Cell Ontology.
ELANE hgnc:3309 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves ELANE (hgnc:3309). hgnc:3309 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (1 reference)
PMID:11957190 SUPPORT Human Clinical
"Recent genetic, molecular, and cellular studies have shown that autosomal-dominant cyclic neutropenia and sporadic cases of this disease are due to a mutation in the gene for neutrophil elastase (ELA2), located at 19p13.3. This enzyme is synthesized in neutrophil precursors early in the process..."
Names the causal gene and locates elastase synthesis in neutrophil precursors, which is the basis for lineage specificity.
Endoplasmic Reticulum Stress and Unfolded Protein Response
In CD34+ cells taken at the neutrophil nadir, ELANE and the unfolded protein response genes ATF6, BiP, CHOP and PERK are all raised while the antiapoptotic genes BCL2 and BCL2L1 are reduced, with increased reactive oxygen species and gH2AX. The measurement is made in patient marrow at a defined point in the cycle, which is what makes this node unusually well grounded for a mechanism of this kind.
response to endoplasmic reticulum stress GO:0034976 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased response to endoplasmic reticulum stress (GO:0034976). GO:0034976 is a biological process from the Gene Ontology. ↑ INCREASED PERK-mediated unfolded protein response GO:0036499 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased PERK-mediated unfolded protein response (GO:0036499). GO:0036499 is a biological process from the Gene Ontology. ↑ INCREASED
Show evidence (2 references)
PMID:32083314 SUPPORT Human Clinical
"we found that mRNA expression levels of ELANE and unfolded protein response (UPR)-related genes (ATF6, BiP (HSPA5), CHOP (DDIT3), and PERK (EIF2AK3)) were elevated, but antiapoptotic genes (Bcl-2 (BCL2) and bcl-xL (BCL2L1)) were reduced in CD34+ cells tested at the ANC nadir."
Direct measurement of unfolded protein response activation and loss of antiapoptotic signalling in patient progenitors at the nadir.
PMID:32299910 REFUTE In Vitro
"Using an inducible expression system, we observed that this ELANE mutation diminishes enzymatic activity and granulocytic differentiation without significantly affecting cell proliferation, cell death, or UPR induction in murine myeloblast 32D and human promyelocytic NB4 cells."
Argues against the unfolded protein response being necessary, since impaired differentiation occurred without it. Recorded here as a genuine challenge to this node, with the caveat that the mutation studied (p.G185R) is a severe congenital neutropenia allele rather than a cyclic one.
Apoptosis of Granulocytic Progenitors
Accelerated death of neutrophil precursors, producing ineffective granulopoiesis and, in the marrow, myeloid maturation arrest. This is the step that converts a protein-folding defect into a blood count.
hematopoietic stem cell CL:0000037 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves hematopoietic stem cell (CL:0000037). CL:0000037 is a cell type from the Cell Ontology.
apoptotic process GO:0006915 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased apoptotic process (GO:0006915). GO:0006915 is a biological process from the Gene Ontology. ↑ INCREASED granulocyte differentiation GO:0030851 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased granulocyte differentiation (GO:0030851). GO:0030851 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:11957190 SUPPORT Human Clinical
"It is currently presumed that the mutant neutrophil elastase functions aberrantly within the cells to accelerate apoptosis of the precursors, resulting in effective and oscillatory production."
States accelerated precursor apoptosis as the mechanism linking the mutant protein to oscillatory production. The source is explicit that this is presumed.
Oscillatory Granulopoiesis
The defining feature, and the reason this disease is interesting beyond haematology: a genetic lesion producing not a fixed deficit but a stable oscillation. Marrow sampling at the two ends of the cycle shows the mechanism in motion, with stem and progenitor cells accumulating at the nadir and producing fewer granulocyte colonies at the peak.
neutrophil CL:0000775 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neutrophil (CL:0000775). CL:0000775 is a cell type from the Cell Ontology.
Show evidence (2 references)
PMID:32083314 SUPPORT Human Clinical
"We performed analysis of bone marrow (BM) subpopulations in CyN patients at the peak and the nadir of the ANC cycle and detected high proportions of BM hematopoietic stem cells (HSCs) and hematopoietic stem and progenitor cells (HSPCs) at the nadir of the ANC cycle, as compared with the peak."
Documents the marrow compartment shifting in antiphase with the blood count, which is the direct observation of the oscillation.
PMID:11957190 SUPPORT Human Clinical
"Fluctuations in blood cells are due to oscillatory production of cells by the bone marrow."
Locates the oscillation in marrow production rather than in peripheral consumption or margination.
Recurrent Infection and Mucosal Inflammation
The clinical disease: recurrent fever, mouth ulcers, gingivitis, pharyngitis, sinusitis, cervical adenopathy and cellulitis, all timed to the nadirs. It is less severe than in congenital neutropenia, and between episodes patients are well.
Show evidence (2 references)
PMID:20301705 SUPPORT Human Clinical
"ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy."
Enumerates the clinical manifestations that constitute this endpoint.
PMID:20301705 SUPPORT Human Clinical
"Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia."
Grades the severity of this endpoint against the allelic disorder, which is the main clinical distinction between the two.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Cyclic Hematopoiesis Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

8
Blood 2
Cyclically Decreased Neutrophil Count Cyclically decreased total neutrophil count HP:0040289 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cyclically decreased total neutrophil count (HP:0040289), qualified as temporality recurrent. HP:0040289 is a phenotype from the Human Phenotype Ontology.
Temporal: RECURRENT
Show evidence (1 reference)
PMID:32083314 SUPPORT Human Clinical
"Cyclic neutropenia (CyN) is a hematologic disorder in which peripheral blood absolute neutrophil counts (ANCs) show cycles of approximately 21-day intervals."
Defines the oscillation and its period, which is the phenotype itself.
Myeloid Maturation Arrest in Bone Marrow Cyclic neutropenia in myeloid maturation arrest in bone marrow HP:0410254 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cyclic neutropenia in myeloid maturation arrest in bone marrow (HP:0410254). HP:0410254 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:32083314 SUPPORT Human Clinical
"BM HSPCs produced fewer granulocyte colony-forming unit colonies at the ANC peak."
Demonstrates impaired proliferation and maturation of myeloid progenitors, which is what the HPO term asserts, rather than only a reduced granulocyte count.
PMID:23855177 SUPPORT Human Clinical
"A bone marrow cytology test during a neutropenic period demonstrated a decrease in granulocyte count."
The corresponding cytological finding in an individual patient during the neutropenic phase.
Cardiovascular 1
Cervical Lymphadenopathy HP:0025289 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cervical lymphadenopathy (HP:0025289). HP:0025289 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy."
Names cervical adenopathy among the defining manifestations.
Head and Neck 3
Recurrent Oral Ulceration FREQUENT Recurrent aphthous stomatitis HP:0011107 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Recurrent aphthous stomatitis (HP:0011107), qualified as temporality recurrent. HP:0011107 is a phenotype from the Human Phenotype Ontology.
Temporal: RECURRENT
Show evidence (2 references)
PMID:20301705 SUPPORT Human Clinical
"Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts."
Names oral ulceration at three-weekly intervals as a defining feature, which supports both the phenotype and the FREQUENT band.
PMID:23855177 SUPPORT Human Clinical
"CN can easily be misdiagnosed as major recurrent aphthous stomatitis (MaRAS) or aggressive periodontitis (AP) in dental clinics."
Records the specific misdiagnosis risk that makes this phenotype clinically important to recognise.
Periodontitis HP:0000704 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Periodontitis (HP:0000704). HP:0000704 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:23855177 SUPPORT Human Clinical
"An 8-year-old boy presented with a history of recurrent oral ulcers, periodontal destruction, pharyngitis and otitis media since the age of 3 months."
Documents periodontal destruction as a presenting feature.
Gingivitis HP:0000230 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Gingivitis (HP:0000230). HP:0000230 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy."
Names gingivitis among the oropharyngeal manifestations.
Metabolism 1
Recurrent Fever FREQUENT HP:0001954 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Recurrent fever (HP:0001954), qualified as temporality recurrent. HP:0001954 is a phenotype from the Human Phenotype Ontology.
Temporal: RECURRENT
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts."
Establishes recurrent fever at three-weekly intervals as a defining feature, which supports both the phenotype and the FREQUENT band.
Musculoskeletal 1
Cellulitis HP:0100658 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cellulitis (HP:0100658). HP:0100658 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"Cellulitis, especially perianal cellulitis, is common during neutropenic periods."
Names cellulitis and its characteristic site, timed to the neutropenic periods.
🧬

Genetic Associations

1
ELANE (Heterozygous Missense Mutation, Autosomal Dominant)
Gene: ELANE hgnc:3309 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is ELANE (hgnc:3309). hgnc:3309 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (3 references)
PMID:23463630 SUPPORT Human Clinical
"CyN-associated mutations were predicted to be more benign than CN-associated mutations, but the mutation severity largely overlapped."
Establishes that the two mutation spectra differ in tendency but overlap, which is why genotype is not predictive.
PMID:20582973 SUPPORT Human Clinical
"One patient with CN had the same S97L ELANE mutation as seven patients with the SCN phenotype."
The single strongest piece of evidence that the ELANE allele alone does not determine which of the two phenotypes appears.
PMID:20582973 SUPPORT Human Clinical
"The coexistence of CN and SCN phenotypes in this kindred with a shared paternal haplotype strongly suggests both a role for modifying genes in determination of congenital neutropenia disease phenotypes, and the classification of CN and SCN within a spectrum of phenotypes expressing varying..."
States the modifier-gene interpretation and the spectrum classification that this entry adopts.
💊

Medical Actions

3
Granulocyte Colony-Stimulating Factor
Action: colony-stimulating factor therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is colony-stimulating factor therapy (NCIT:C15515). NCIT:C15515 is a clinical intervention from the NCI Thesaurus. Ontology label: Colony-Stimulating Factor Therapy NCIT:C15515
Agent: filgrastim NCIT:C1474 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses filgrastim (NCIT:C1474). NCIT:C1474 is a therapeutic agent from the NCI Thesaurus.
The mainstay. Long-term daily or alternate-day G-CSF at 1 to 5 micrograms per kilogram per day reduces fever, mouth ulcers and other inflammatory events. Note the mechanistic irony: G-CSF-driven compensatory proliferation is part of the oscillation in the first place, and treatment works by raising the nadir rather than by abolishing the cycle.
Mechanism Target:
MODULATES Oscillatory Granulopoiesis — Pharmacological G-CSF drives granulocytic proliferation and differentiation, raising the neutrophil count achieved at the nadir.
Show evidence (1 reference)
PMID:32083314 SUPPORT Human Clinical
"There is a cyclic balance between ER stress-induced apoptosis of HSPCs and compensatory G-CSF-stimulated HSPC proliferation followed by granulocytic differentiation."
Identifies G-CSF-stimulated proliferation as the arm of the cycle that this treatment augments.
Show evidence (2 references)
PMID:11957190 SUPPORT Human Clinical
"Cyclic neutropenia is effectively treated with granulocyte colony-stimulating factor (G-CSF), usually at doses of 1 to 5 microg/kg/d (median dose, 2.5 microg/kg/d). Long-term, daily, or alternate-day administration reduces fever, mouth ulcers, and other inflammatory events associated with this disorder."
Gives the dose range and the clinical benefit obtained.
PMID:23855177 SUPPORT Human Clinical
"During a 2-year follow-up, his symptoms were well controlled by regular administration of granulocyte colony-stimulating factor and periodontal maintenance."
Individual-level confirmation of symptom control on maintenance G-CSF, alongside dental care.
Prompt Antimicrobial Treatment of Febrile Episodes
Action: antibiotic therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is antibiotic therapy (NCIT:C15620). NCIT:C15620 is a clinical intervention from the NCI Thesaurus. Ontology label: Antibiotic Therapy NCIT:C15620
All fevers and infections require prompt evaluation and treatment. Abdominal pain in particular needs assessment, because of the risk of a lethal complication during the neutropenic window.
Mechanism Target:
INHIBITS Recurrent Infection and Mucosal Inflammation — Treats the infectious consequence of each nadir. It does not touch the granulopoietic defect upstream, which is why it is symptomatic rather than disease-modifying.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"Treatment of manifestations: All fevers and infections require prompt evaluation and treatment."
States that the infectious manifestations are what this intervention targets.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"Treatment of manifestations: All fevers and infections require prompt evaluation and treatment."
States the management principle for febrile episodes.
Dental Hygiene and Periodontal Maintenance
Platform: Behavioral / lifestyle
Good dental hygiene with regular periodontal maintenance, alongside G-CSF. It is listed here rather than folded into supportive care because periodontitis and gingivitis are modelled as phenotypes of this disease, and this is the intervention that addresses them.
Mechanism Target:
INHIBITS Recurrent Infection and Mucosal Inflammation — Reduces the oral bacterial burden that the neutropenic windows would otherwise allow to produce gingival and periodontal destruction.
Show evidence (1 reference)
PMID:23855177 SUPPORT Human Clinical
"During a 2-year follow-up, his symptoms were well controlled by regular administration of granulocyte colony-stimulating factor and periodontal maintenance."
Records periodontal maintenance as part of what controlled the oral manifestations, alongside G-CSF.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"Prevention of secondary complications: Good dental hygiene; routine immunizations."
States dental hygiene as a recommended preventive measure in this condition.
🔬

Diagnosis

2
Serial absolute neutrophil counts (PRESENT)
The diagnosis rests on demonstrating the oscillation, which requires repeated counts over at least six weeks rather than a single measurement. A single normal count does not exclude the disease, because it may have been taken at the peak.
Show evidence (1 reference)
PMID:23855177 SUPPORT Human Clinical
"Repeated, routine blood tests showed 1-week-long neutropenic periods that occurred at intervals of 2 weeks."
Shows that repeated sampling is what reveals the pattern, and incidentally that the period is not always the textbook twenty-one days.
ELANE molecular genetic testing (PRESENT)
Identification of a heterozygous pathogenic ELANE variant confirms the diagnosis. A negative result does not exclude it, since ELANE mutations are found in only about 55% of cyclic neutropenia patients.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"The diagnosis of ELANE-related neutropenia is established in a proband with suggestive clinical findings and the identification of a heterozygous pathogenic variant in ELANE through molecular genetic testing."
States the molecular diagnostic criterion.
📈

Progression

3
Childhood and adolescence
Diagnosed usually within the first year of life. The course is a rhythm rather than a decline: fever, oral ulceration and infection at each nadir, good health between them. Cellulitis, characteristically perianal, occurs in the neutropenic windows.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"Cellulitis, especially perianal cellulitis, is common during neutropenic periods. Between neutropenic periods, affected individuals are generally healthy."
Describes the alternating pattern that characterises this phase.
Adulthood
Symptoms improve with age, which is the opposite of the trajectory in severe congenital neutropenia.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"Between neutropenic periods, affected individuals are generally healthy. Symptoms improve in adulthood."
States the improvement with age, alongside the inter-episode good health that characterises the earlier phase.
Long-term outcome
The point at which this disease diverges completely from its allelic partner, and the reason the two are curated separately. Severe congenital neutropenia carries a 15 to 25% risk of myelodysplasia or acute myeloid leukaemia after fifteen years of G-CSF. Cyclic neutropenia carries no recognised risk, treated or untreated. The divergence is attributed to disease severity rather than to the ELANE mutation itself, so it is not predictable from the genotype.
Show evidence (3 references)
PMID:20301705 SUPPORT Human Clinical
"Cyclic neutropenia is not associated with risk of malignancy or conversion to leukemia."
States the absence of malignant risk directly.
PMID:11957190 SUPPORT Human Clinical
"Leukemic transformation is not a recognized risk for cyclic neutropenia, with or without treatment with G-CSF."
Confirms the absence of risk and specifies that it holds under G-CSF treatment, which is the clinically relevant question.
PMID:23463630 SUPPORT Human Clinical
"Specific ELANE mutations have limited predictive value for leukemogenesis; the risk for leukemia was correlated with disease severity rather than with occurrence of an ELANE mutation."
Attributes leukaemic risk to severity rather than to the gene, which is why the allelic disorder diverges here.
🌍

Epidemiology

2
Age at diagnosis
Usually recognised within the first year of life, from the pattern of approximately three-weekly fever and oral ulceration together with regular oscillation of the blood counts. Symptoms tend to improve in adulthood.
Show evidence (1 reference)
PMID:20301705 SUPPORT Human Clinical
"Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts."
Gives the typical age at diagnosis and the clinical pattern that prompts it.
ELANE mutation frequency
In the largest screened series, ELANE mutations were found in 55% of cyclic neutropenia patients, a higher detection rate than in severe congenital neutropenia.
Show evidence (1 reference)
PMID:23463630 SUPPORT Human Clinical
"We found 116 different mutations in 162 (41%) CN patients and 26 in 51 (55%) CyN patients, 69 of them were novel."
Gives the ELANE detection rate in cyclic neutropenia alongside the congenital neutropenia comparison.
🐁

Animal Models

2
G193X Elane transgenic mouse
A targeted Elane mutation reproducing a human severe congenital neutropenia allele. It is included here because of what it fails to do: the mice are not neutropenic, which is a real problem for the unfolded protein response model as a complete account.
Species
Mouse
Genotype
G193X Elane
Publication
Show evidence (1 reference)
PMID:21285438 SUPPORT Model Organism
"To test this model, we generated transgenic mice carrying a targeted mutation of Elane (G193X) reproducing a mutation found in SCN."
Establishes the model and the human allele it reproduces.
Grey Collie canine cyclic hematopoiesis
The classical animal model, described in Grey Collies as the lethal grey syndrome. It reproduces the oscillation itself, on a twelve-day rather than a twenty-one-day cycle, and historically it shaped how the human disease was understood. It is genetically distinct: the canine disease is a recessive AP3B1 defect, not an ELANE one.
Species
Dog
Genotype
AP3B1 frameshift, homozygous
Publication
Show evidence (1 reference)
PMID:2979797 SUPPORT Model Organism
"Canine cyclic hematopoiesis (CH) was first described in Gray Collies as the lethal gray syndrome, and was subsequently shown to be a counterpart of human cyclic neutropenia (CN)."
Establishes the model and its relationship to the human disease.
{ }

Source YAML

click to show
name: Cyclic Hematopoiesis
creation_date: '2026-09-03T09:00:00Z'
description: >-
  An autosomal dominant disorder of granulopoiesis in which the absolute
  neutrophil count oscillates on a regular cycle of roughly 21 days, falling to
  severely neutropenic levels and recovering to near normal. Most cases carry a
  heterozygous ELANE mutation. The prevailing model is that mutant neutrophil
  elastase misfolds, provokes endoplasmic reticulum stress and an unfolded
  protein response in granulocytic progenitors, and kills them; the oscillation
  arises because progenitor depletion drives compensatory G-CSF-stimulated
  proliferation, which then repopulates the compartment until the unfolded
  protein response overtakes it again. Clinically the disease is a rhythm of
  fever, mouth ulceration and infection at each nadir, with good health in
  between. Unlike severe congenital neutropenia, which shares the same gene, it
  carries no recognised risk of leukaemic transformation.
categories:
- Inborn Error of Immunity
- Disorder of Granulopoiesis
- Protein Misfolding Disorder
parents:
- congenital neutropenia
synonyms:
- cyclic neutropenia
- periodic neutropenia
- cyclic agranulocytosis
epidemiology:
- name: Age at diagnosis
  description: >-
    Usually recognised within the first year of life, from the pattern of
    approximately three-weekly fever and oral ulceration together with regular
    oscillation of the blood counts. Symptoms tend to improve in adulthood.
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Cyclic neutropenia is usually diagnosed within the first year of life based on
      approximately three-week intervals of fever and oral ulcerations and regular oscillations
      of blood cell counts.
    explanation: Gives the typical age at diagnosis and the clinical pattern that prompts it.
- name: ELANE mutation frequency
  description: >-
    In the largest screened series, ELANE mutations were found in 55% of cyclic
    neutropenia patients, a higher detection rate than in severe congenital
    neutropenia.
  evidence:
  - reference: PMID:23463630
    reference_title: The spectrum of ELANE mutations and their implications in severe congenital and cyclic
      neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We found 116 different mutations in 162 (41%) CN patients and 26 in 51 (55%) CyN
      patients, 69 of them were novel.
    explanation: Gives the ELANE detection rate in cyclic neutropenia alongside the congenital
      neutropenia comparison.
pathophysiology:
- name: ELANE Mutation and Neutrophil Elastase Misfolding
  description: >-
    The initiating lesion. A heterozygous mutation in ELANE yields a neutrophil
    elastase that misfolds. Elastase is synthesised in neutrophil precursors early
    in primary granule formation, which is why the consequences fall on the
    granulocytic lineage specifically rather than on cells generally.
  genes:
  - preferred_term: ELANE
    term:
      id: hgnc:3309
      label: ELANE
  cell_types:
  - preferred_term: promyelocyte
    term:
      id: CL:0000836
      label: promyelocyte
  evidence:
  - reference: PMID:11957190
    reference_title: Cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Recent genetic, molecular, and cellular studies have shown that autosomal-dominant
      cyclic neutropenia and sporadic cases of this disease are due to a mutation in the gene
      for neutrophil elastase (ELA2), located at 19p13.3. This enzyme is synthesized in neutrophil
      precursors early in the process of primary granule formation.
    explanation: Names the causal gene and locates elastase synthesis in neutrophil precursors,
      which is the basis for lineage specificity.
  downstream:
  - target: Endoplasmic Reticulum Stress and Unfolded Protein Response
    causal_link_type: DIRECT
    description: Misfolded elastase accumulating in the endoplasmic reticulum triggers the
      stress response.
    evidence:
    - reference: PMID:21285438
      reference_title: Activation of the unfolded protein response is associated with impaired granulopoiesis
        in transgenic mice expressing mutant Elane.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: 'Recent data suggest a model in which ELANE mutations result in NE protein misfolding,
        induction of endoplasmic reticulum (ER) stress, activation of the unfolded protein response
        (UPR), and ultimately a block in granulocytic differentiation.'
      explanation: States the misfolding-to-ER-stress step that this edge asserts, and is
        explicit that it is a model.
- name: Endoplasmic Reticulum Stress and Unfolded Protein Response
  description: >-
    In CD34+ cells taken at the neutrophil nadir, ELANE and the unfolded protein
    response genes ATF6, BiP, CHOP and PERK are all raised while the antiapoptotic
    genes BCL2 and BCL2L1 are reduced, with increased reactive oxygen species and
    gH2AX. The measurement is made in patient marrow at a defined point in the
    cycle, which is what makes this node unusually well grounded for a mechanism
    of this kind.
  biological_processes:
  - preferred_term: response to endoplasmic reticulum stress
    modifier: INCREASED
    term:
      id: GO:0034976
      label: response to endoplasmic reticulum stress
  - preferred_term: PERK-mediated unfolded protein response
    modifier: INCREASED
    term:
      id: GO:0036499
      label: PERK-mediated unfolded protein response
  evidence:
  - reference: PMID:32083314
    reference_title: New insights into the pathomechanism of cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'we found that mRNA expression levels of ELANE and unfolded protein response (UPR)-related
      genes (ATF6, BiP (HSPA5), CHOP (DDIT3), and PERK (EIF2AK3)) were elevated, but antiapoptotic
      genes (Bcl-2 (BCL2) and bcl-xL (BCL2L1)) were reduced in CD34+ cells tested at the ANC
      nadir.'
    explanation: Direct measurement of unfolded protein response activation and loss of
      antiapoptotic signalling in patient progenitors at the nadir.
  - reference: PMID:32299910
    reference_title: 'Inducible expression of a disease-associated ELANE mutation impairs granulocytic differentiation,
      without eliciting an unfolded protein response.'
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: 'Using an inducible expression system, we observed that this ELANE mutation diminishes
      enzymatic activity and granulocytic differentiation without significantly affecting cell
      proliferation, cell death, or UPR induction in murine myeloblast 32D and human promyelocytic
      NB4 cells.'
    explanation: Argues against the unfolded protein response being necessary, since impaired
      differentiation occurred without it. Recorded here as a genuine challenge to this node,
      with the caveat that the mutation studied (p.G185R) is a severe congenital neutropenia
      allele rather than a cyclic one.
  downstream:
  - target: Apoptosis of Granulocytic Progenitors
    causal_link_type: DIRECT
    description: The unfolded protein response, with antiapoptotic gene expression suppressed,
      kills the progenitors rather than merely stalling them.
    evidence:
    - reference: PMID:32083314
      reference_title: New insights into the pathomechanism of cyclic neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: There is a cyclic balance between ER stress-induced apoptosis of HSPCs and
        compensatory G-CSF-stimulated HSPC proliferation followed by granulocytic differentiation.
      explanation: Names ER-stress-induced apoptosis of progenitors as one arm of the balance.
- name: Apoptosis of Granulocytic Progenitors
  description: >-
    Accelerated death of neutrophil precursors, producing ineffective granulopoiesis
    and, in the marrow, myeloid maturation arrest. This is the step that converts a
    protein-folding defect into a blood count.
  cell_types:
  - preferred_term: hematopoietic stem cell
    term:
      id: CL:0000037
      label: hematopoietic stem cell
  biological_processes:
  - preferred_term: apoptotic process
    modifier: INCREASED
    term:
      id: GO:0006915
      label: apoptotic process
  - preferred_term: granulocyte differentiation
    modifier: DECREASED
    term:
      id: GO:0030851
      label: granulocyte differentiation
  evidence:
  - reference: PMID:11957190
    reference_title: Cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: It is currently presumed that the mutant neutrophil elastase functions aberrantly
      within the cells to accelerate apoptosis of the precursors, resulting in effective and
      oscillatory production.
    explanation: States accelerated precursor apoptosis as the mechanism linking the mutant
      protein to oscillatory production. The source is explicit that this is presumed.
  downstream:
  - target: Oscillatory Granulopoiesis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Progenitor depletion raises G-CSF, which drives compensatory proliferation; the
      repopulated compartment is then hit by the unfolded protein response again, and the loop
      repeats with a period of about three weeks.
    evidence:
    - reference: PMID:32083314
      reference_title: New insights into the pathomechanism of cyclic neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: 'We suggest that in CyN patients, some HSPCs escape the UPR-induced endoplasmic
        reticulum (ER) stress and proliferate in response to granulocyte colony-stimulating factor
        (G-CSF) to a certain threshold at which UPR again affects the majority of HSPCs.'
      explanation: States the feedback loop that generates the oscillation, and does so as an
        explicit suggestion rather than an established fact.
- name: Oscillatory Granulopoiesis
  description: >-
    The defining feature, and the reason this disease is interesting beyond
    haematology: a genetic lesion producing not a fixed deficit but a stable
    oscillation. Marrow sampling at the two ends of the cycle shows the mechanism
    in motion, with stem and progenitor cells accumulating at the nadir and
    producing fewer granulocyte colonies at the peak.
  cell_types:
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  evidence:
  - reference: PMID:32083314
    reference_title: New insights into the pathomechanism of cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'We performed analysis of bone marrow (BM) subpopulations in CyN patients at the
      peak and the nadir of the ANC cycle and detected high proportions of BM hematopoietic
      stem cells (HSCs) and hematopoietic stem and progenitor cells (HSPCs) at the nadir of
      the ANC cycle, as compared with the peak.'
    explanation: Documents the marrow compartment shifting in antiphase with the blood count,
      which is the direct observation of the oscillation.
  - reference: PMID:11957190
    reference_title: Cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Fluctuations in blood cells are due to oscillatory production of cells by the bone
      marrow.
    explanation: Locates the oscillation in marrow production rather than in peripheral
      consumption or margination.
  downstream:
  - target: Cyclically Decreased Neutrophil Count
    causal_link_type: DIRECT
    description: Oscillating marrow output is measured directly as the oscillating peripheral
      absolute neutrophil count.
    evidence:
    - reference: PMID:11957190
      reference_title: Cyclic neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Fluctuations in blood cells are due to oscillatory production of cells by the bone
        marrow.
      explanation: States that the blood-count oscillation is produced by the marrow oscillation,
        which is exactly this edge.
  - target: Myeloid Maturation Arrest in Bone Marrow
    causal_link_type: DIRECT
    description: The same cycle is visible in the marrow as reduced granulocytic colony output
      and a fall in granulocyte numbers during the neutropenic phase.
    evidence:
    - reference: PMID:32083314
      reference_title: New insights into the pathomechanism of cyclic neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: BM HSPCs produced fewer granulocyte colony-forming unit colonies at the ANC peak.
      explanation: The marrow correlate of the cycle, measured at a defined point in it.
  - target: Recurrent Infection and Mucosal Inflammation
    causal_link_type: DIRECT
    description: At each nadir the neutrophil count is severely low for several days, and it is
      during those windows that infection and mucosal breakdown occur.
    evidence:
    - reference: PMID:20301705
      reference_title: ELANE-Related Neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Cellulitis, especially perianal cellulitis, is common during neutropenic periods.
        Between neutropenic periods, affected individuals are generally healthy.
      explanation: Ties the infectious events specifically to the neutropenic windows, which is
        what makes this edge cyclical rather than constant.
- name: Recurrent Infection and Mucosal Inflammation
  description: >-
    The clinical disease: recurrent fever, mouth ulcers, gingivitis, pharyngitis,
    sinusitis, cervical adenopathy and cellulitis, all timed to the nadirs. It is
    less severe than in congenital neutropenia, and between episodes patients are
    well.
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia,
      both of which are primary hematologic disorders characterized by recurrent fever, skin
      and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis),
      and cervical adenopathy.'
    explanation: Enumerates the clinical manifestations that constitute this endpoint.
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Infectious complications are generally more severe in congenital neutropenia than
      in cyclic neutropenia.
    explanation: Grades the severity of this endpoint against the allelic disorder, which is the
      main clinical distinction between the two.
  downstream:
  - target: Recurrent Fever
    causal_link_type: DIRECT
    description: Fever recurs with each neutropenic episode.
    evidence:
    - reference: PMID:20301705
      reference_title: ELANE-Related Neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Cyclic neutropenia is usually diagnosed within the first year of life based on
        approximately three-week intervals of fever and oral ulcerations and regular oscillations
        of blood cell counts.
      explanation: Ties the fever to the three-weekly cycle of this endpoint.
  - target: Recurrent Oral Ulceration
    causal_link_type: DIRECT
    description: Oral ulceration accompanies each nadir, alongside the fever.
    evidence:
    - reference: PMID:20301705
      reference_title: ELANE-Related Neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Cyclic neutropenia is usually diagnosed within the first year of life based on
        approximately three-week intervals of fever and oral ulcerations and regular oscillations
        of blood cell counts.
      explanation: Ties the oral ulceration to the same cycle.
  - target: Gingivitis
    causal_link_type: DIRECT
    description: Gingival inflammation is part of the oropharyngeal inflammatory response to
      repeated neutropenic episodes.
    evidence:
    - reference: PMID:20301705
      reference_title: ELANE-Related Neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: 'ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia,
        both of which are primary hematologic disorders characterized by recurrent fever, skin
        and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis),
        and cervical adenopathy.'
      explanation: Names gingivitis among the oropharyngeal manifestations of this endpoint.
  - target: Cervical Lymphadenopathy
    causal_link_type: DIRECT
    description: Cervical adenopathy accompanies the recurrent oropharyngeal inflammation.
    evidence:
    - reference: PMID:20301705
      reference_title: ELANE-Related Neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: 'ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia,
        both of which are primary hematologic disorders characterized by recurrent fever, skin
        and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis),
        and cervical adenopathy.'
      explanation: Names cervical adenopathy among the manifestations of this endpoint.
  - target: Cellulitis
    causal_link_type: DIRECT
    description: Soft tissue infection, characteristically perianal, occurring specifically during
      the neutropenic windows.
    evidence:
    - reference: PMID:20301705
      reference_title: ELANE-Related Neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Cellulitis, especially perianal cellulitis, is common during neutropenic periods.
      explanation: Times the cellulitis to the neutropenic periods, which is what makes it a
        consequence of this endpoint.
  - target: Periodontitis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Repeated episodes of neutropenic gingival infection produce cumulative
      periodontal destruction.
    evidence:
    - reference: PMID:23855177
      reference_title: Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: An 8-year-old boy presented with a history of recurrent oral ulcers, periodontal
        destruction, pharyngitis and otitis media since the age of 3 months.
      explanation: Documents periodontal destruction developing on a background of recurrent
        oral ulceration and infection, which is the sequence this edge asserts.

phenotypes:
- category: Hematologic
  name: Cyclically Decreased Neutrophil Count
  description: >-
    The defining laboratory phenotype: regular oscillation of the absolute
    neutrophil count from near normal to severely low, with a period of about
    twenty-one days.
  phenotype_term:
    preferred_term: Cyclically decreased total neutrophil count
    term:
      id: HP:0040289
      label: Cyclically decreased total neutrophil count
    temporality: RECURRENT
  diagnostic: true
  evidence:
  - reference: PMID:32083314
    reference_title: New insights into the pathomechanism of cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Cyclic neutropenia (CyN) is a hematologic disorder in which peripheral blood absolute
      neutrophil counts (ANCs) show cycles of approximately 21-day intervals.
    explanation: Defines the oscillation and its period, which is the phenotype itself.
- category: Hematologic
  name: Myeloid Maturation Arrest in Bone Marrow
  description: >-
    The marrow correlate of the blood phenotype, seen as a fall in granulocyte
    numbers during the neutropenic phase.
  phenotype_term:
    preferred_term: Cyclic neutropenia in myeloid maturation arrest in bone marrow
    term:
      id: HP:0410254
      label: Cyclic neutropenia in myeloid maturation arrest in bone marrow
  evidence:
  - reference: PMID:32083314
    reference_title: New insights into the pathomechanism of cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: BM HSPCs produced fewer granulocyte colony-forming unit colonies at the ANC peak.
    explanation: Demonstrates impaired proliferation and maturation of myeloid progenitors,
      which is what the HPO term asserts, rather than only a reduced granulocyte count.
  - reference: PMID:23855177
    reference_title: Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: A bone marrow cytology test during a neutropenic period demonstrated a decrease in
      granulocyte count.
    explanation: The corresponding cytological finding in an individual patient during the
      neutropenic phase.
- category: Constitutional
  name: Recurrent Fever
  frequency: FREQUENT
  description: >-
    Fever recurring at roughly three-weekly intervals, in step with the neutrophil
    nadir. The regularity of the interval is itself the diagnostic clue.
  phenotype_term:
    preferred_term: Recurrent fever
    term:
      id: HP:0001954
      label: Recurrent fever
    temporality: RECURRENT
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Cyclic neutropenia is usually diagnosed within the first year of life based on
      approximately three-week intervals of fever and oral ulcerations and regular oscillations
      of blood cell counts.
    explanation: Establishes recurrent fever at three-weekly intervals as a defining feature,
      which supports both the phenotype and the FREQUENT band.
- category: Oral
  name: Recurrent Oral Ulceration
  frequency: FREQUENT
  description: >-
    Painful recurrent oral ulcers accompanying each nadir. In practice this is
    frequently misread as major recurrent aphthous stomatitis, and the dentist is
    often the first clinician to see the patient.
  phenotype_term:
    preferred_term: Recurrent aphthous stomatitis
    term:
      id: HP:0011107
      label: Recurrent aphthous stomatitis
    temporality: RECURRENT
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Cyclic neutropenia is usually diagnosed within the first year of life based on
      approximately three-week intervals of fever and oral ulcerations and regular oscillations
      of blood cell counts.
    explanation: Names oral ulceration at three-weekly intervals as a defining feature, which
      supports both the phenotype and the FREQUENT band.
  - reference: PMID:23855177
    reference_title: Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: CN can easily be misdiagnosed as major recurrent aphthous stomatitis (MaRAS) or
      aggressive periodontitis (AP) in dental clinics.
    explanation: Records the specific misdiagnosis risk that makes this phenotype clinically
      important to recognise.
- category: Oral
  name: Periodontitis
  description: >-
    Periodontal destruction from repeated neutropenic episodes, which can be the
    presenting problem and can progress to permanent tissue loss if the underlying
    cause is missed.
  phenotype_term:
    preferred_term: Periodontitis
    term:
      id: HP:0000704
      label: Periodontitis
  evidence:
  - reference: PMID:23855177
    reference_title: Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: An 8-year-old boy presented with a history of recurrent oral ulcers, periodontal
      destruction, pharyngitis and otitis media since the age of 3 months.
    explanation: Documents periodontal destruction as a presenting feature.
- category: Oral
  name: Gingivitis
  description: >-
    Gingival inflammation, part of the oropharyngeal inflammatory picture common
    to ELANE-related neutropenia.
  phenotype_term:
    preferred_term: Gingivitis
    term:
      id: HP:0000230
      label: Gingivitis
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia,
      both of which are primary hematologic disorders characterized by recurrent fever, skin
      and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis),
      and cervical adenopathy.'
    explanation: Names gingivitis among the oropharyngeal manifestations.
- category: Immunologic
  name: Cellulitis
  description: >-
    Soft tissue infection during neutropenic windows, characteristically perianal.
  phenotype_term:
    preferred_term: Cellulitis
    term:
      id: HP:0100658
      label: Cellulitis
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Cellulitis, especially perianal cellulitis, is common during neutropenic periods.
    explanation: Names cellulitis and its characteristic site, timed to the neutropenic periods.
- category: Immunologic
  name: Cervical Lymphadenopathy
  description: >-
    Cervical adenopathy accompanying the recurrent oropharyngeal inflammation.
  phenotype_term:
    preferred_term: Cervical lymphadenopathy
    term:
      id: HP:0025289
      label: Cervical lymphadenopathy
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia,
      both of which are primary hematologic disorders characterized by recurrent fever, skin
      and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis),
      and cervical adenopathy.'
    explanation: Names cervical adenopathy among the defining manifestations.
genetic:
- name: ELANE
  gene_term:
    preferred_term: ELANE
    term:
      id: hgnc:3309
      label: ELANE
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  association: Heterozygous Missense Mutation, Autosomal Dominant
  case_fractions:
  - population: Cyclic neutropenia patients screened in the Hannover/SCNIR cohort
    case_fraction_percent: 55.0
    cohort_size: 51
    notes: Detection rate is higher in cyclic neutropenia than in severe congenital
      neutropenia, where the same screen found 41%.
    evidence:
    - reference: PMID:23463630
      reference_title: The spectrum of ELANE mutations and their implications in severe congenital and cyclic
        neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: We found 116 different mutations in 162 (41%) CN patients and 26 in 51 (55%) CyN
        patients, 69 of them were novel.
      explanation: Gives the cyclic-neutropenia denominator and detection rate alongside the
        congenital-neutropenia comparison.
  notes: >-
    Genotype does not cleanly predict phenotype. Cyclic and severe congenital
    neutropenia have partly distinct mutation spectra, but the severity
    distributions overlap, and one kindred is documented in which the same S97L
    allele on a shared paternal haplotype produced cyclic neutropenia in one child
    and severe congenital neutropenia in seven others. That observation argues for
    modifying genes and for treating the two conditions as a phenotypic spectrum
    rather than as separate diseases.
  evidence:
  - reference: PMID:23463630
    reference_title: The spectrum of ELANE mutations and their implications in severe congenital and cyclic
      neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: CyN-associated mutations were predicted to be more benign than CN-associated
      mutations, but the mutation severity largely overlapped.
    explanation: Establishes that the two mutation spectra differ in tendency but overlap, which
      is why genotype is not predictive.
  - reference: PMID:20582973
    reference_title: 'Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE
      mutation and paternal haplotype: evidence for phenotype determination by modifying genes.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: One patient with CN had the same S97L ELANE mutation as seven patients with the
      SCN phenotype.
    explanation: The single strongest piece of evidence that the ELANE allele alone does not
      determine which of the two phenotypes appears.
  - reference: PMID:20582973
    reference_title: 'Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE
      mutation and paternal haplotype: evidence for phenotype determination by modifying genes.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The coexistence of CN and SCN phenotypes in this kindred with a shared paternal
      haplotype strongly suggests both a role for modifying genes in determination of congenital
      neutropenia disease phenotypes, and the classification of CN and SCN within a spectrum
      of phenotypes expressing varying degrees of the same disease process.
    explanation: States the modifier-gene interpretation and the spectrum classification that
      this entry adopts.
inheritance:
- name: Autosomal dominant
  description: >-
    Autosomal dominant, occurring both as inherited and as sporadic disease. The
    kindred described by Newburger and colleagues also demonstrates paternal
    gonadal mosaicism as a mechanism of recurrence in apparently sporadic families.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:11957190
    reference_title: Cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Recent genetic, molecular, and cellular studies have shown that autosomal-dominant
      cyclic neutropenia and sporadic cases of this disease are due to a mutation in the gene
      for neutrophil elastase (ELA2), located at 19p13.3.
    explanation: States the autosomal dominant inheritance and the existence of sporadic cases.
  - reference: PMID:20582973
    reference_title: 'Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE
      mutation and paternal haplotype: evidence for phenotype determination by modifying genes.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The mutant allele was detected in the donor's spermatozoa, representing 18% of the
      ELANE gene pool, but not in DNA from his lymphocytes, neutrophils, or buccal mucosa,
      indicating gonadal mosaicism.
    explanation: Documents gonadal mosaicism, which is relevant to recurrence risk counselling in
      families with no detectable parental mutation.
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: One parent of a proband is usually affected. De novo pathogenic variants have been
      identified; their frequency is unknown.
    explanation: Gives the transmission pattern and records that de novo variants occur without
      a known rate, which is the counselling-relevant qualifier alongside the mosaicism finding.
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Each child of an individual with an ELANE pathogenic variant has a 50% chance of
      inheriting the variant.
    explanation: The recurrence risk figure itself.
progression:
- phase: Childhood and adolescence
  notes: >-
    Diagnosed usually within the first year of life. The course is a rhythm rather
    than a decline: fever, oral ulceration and infection at each nadir, good health
    between them. Cellulitis, characteristically perianal, occurs in the
    neutropenic windows.
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Cellulitis, especially perianal cellulitis, is common during neutropenic periods.
      Between neutropenic periods, affected individuals are generally healthy.
    explanation: Describes the alternating pattern that characterises this phase.
- phase: Adulthood
  notes: >-
    Symptoms improve with age, which is the opposite of the trajectory in severe
    congenital neutropenia.
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Between neutropenic periods, affected individuals are generally healthy. Symptoms
      improve in adulthood.
    explanation: States the improvement with age, alongside the inter-episode good health that
      characterises the earlier phase.
- phase: Long-term outcome
  notes: >-
    The point at which this disease diverges completely from its allelic partner,
    and the reason the two are curated separately. Severe congenital neutropenia
    carries a 15 to 25% risk of myelodysplasia or acute myeloid leukaemia after
    fifteen years of G-CSF. Cyclic neutropenia carries no recognised risk, treated
    or untreated. The divergence is attributed to disease severity rather than to
    the ELANE mutation itself, so it is not predictable from the genotype.
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Cyclic neutropenia is not associated with risk of malignancy or conversion to
      leukemia.
    explanation: States the absence of malignant risk directly.
  - reference: PMID:11957190
    reference_title: Cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Leukemic transformation is not a recognized risk for cyclic neutropenia, with or
      without treatment with G-CSF.
    explanation: Confirms the absence of risk and specifies that it holds under G-CSF treatment,
      which is the clinically relevant question.
  - reference: PMID:23463630
    reference_title: The spectrum of ELANE mutations and their implications in severe congenital and cyclic
      neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Specific ELANE mutations have limited predictive value for leukemogenesis; the risk
      for leukemia was correlated with disease severity rather than with occurrence of an ELANE
      mutation.
    explanation: Attributes leukaemic risk to severity rather than to the gene, which is why the
      allelic disorder diverges here.
diagnosis:
- name: Serial absolute neutrophil counts
  presence: PRESENT
  description: >-
    The diagnosis rests on demonstrating the oscillation, which requires repeated
    counts over at least six weeks rather than a single measurement. A single
    normal count does not exclude the disease, because it may have been taken at
    the peak.
  evidence:
  - reference: PMID:23855177
    reference_title: Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Repeated, routine blood tests showed 1-week-long neutropenic periods that occurred
      at intervals of 2 weeks.
    explanation: Shows that repeated sampling is what reveals the pattern, and incidentally that
      the period is not always the textbook twenty-one days.
- name: ELANE molecular genetic testing
  presence: PRESENT
  description: >-
    Identification of a heterozygous pathogenic ELANE variant confirms the
    diagnosis. A negative result does not exclude it, since ELANE mutations are
    found in only about 55% of cyclic neutropenia patients.
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The diagnosis of ELANE-related neutropenia is established in a proband with
      suggestive clinical findings and the identification of a heterozygous pathogenic variant
      in ELANE through molecular genetic testing.
    explanation: States the molecular diagnostic criterion.
treatments:
- name: Granulocyte Colony-Stimulating Factor
  description: >-
    The mainstay. Long-term daily or alternate-day G-CSF at 1 to 5 micrograms per
    kilogram per day reduces fever, mouth ulcers and other inflammatory events.
    Note the mechanistic irony: G-CSF-driven compensatory proliferation is part of
    the oscillation in the first place, and treatment works by raising the nadir
    rather than by abolishing the cycle.
  treatment_term:
    preferred_term: colony-stimulating factor therapy
    term:
      id: NCIT:C15515
      label: Colony-Stimulating Factor Therapy
    therapeutic_agent:
    - preferred_term: filgrastim
      term:
        id: NCIT:C1474
        label: Filgrastim
  target_mechanisms:
  - target: Oscillatory Granulopoiesis
    treatment_effect: MODULATES
    description: Pharmacological G-CSF drives granulocytic proliferation and differentiation,
      raising the neutrophil count achieved at the nadir.
    evidence:
    - reference: PMID:32083314
      reference_title: New insights into the pathomechanism of cyclic neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: There is a cyclic balance between ER stress-induced apoptosis of HSPCs and
        compensatory G-CSF-stimulated HSPC proliferation followed by granulocytic differentiation.
      explanation: Identifies G-CSF-stimulated proliferation as the arm of the cycle that this
        treatment augments.
  evidence:
  - reference: PMID:11957190
    reference_title: Cyclic neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'Cyclic neutropenia is effectively treated with granulocyte colony-stimulating factor
      (G-CSF), usually at doses of 1 to 5 microg/kg/d (median dose, 2.5 microg/kg/d). Long-term,
      daily, or alternate-day administration reduces fever, mouth ulcers, and other inflammatory
      events associated with this disorder.'
    explanation: Gives the dose range and the clinical benefit obtained.
  - reference: PMID:23855177
    reference_title: Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: During a 2-year follow-up, his symptoms were well controlled by regular
      administration of granulocyte colony-stimulating factor and periodontal maintenance.
    explanation: Individual-level confirmation of symptom control on maintenance G-CSF, alongside
      dental care.
- name: Prompt Antimicrobial Treatment of Febrile Episodes
  description: >-
    All fevers and infections require prompt evaluation and treatment. Abdominal
    pain in particular needs assessment, because of the risk of a lethal
    complication during the neutropenic window.
  treatment_term:
    preferred_term: antibiotic therapy
    term:
      id: NCIT:C15620
      label: Antibiotic Therapy
  target_mechanisms:
  - target: Recurrent Infection and Mucosal Inflammation
    treatment_effect: INHIBITS
    description: Treats the infectious consequence of each nadir. It does not touch the
      granulopoietic defect upstream, which is why it is symptomatic rather than
      disease-modifying.
    evidence:
    - reference: PMID:20301705
      reference_title: ELANE-Related Neutropenia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: 'Treatment of manifestations: All fevers and infections require prompt evaluation
        and treatment.'
      explanation: States that the infectious manifestations are what this intervention targets.
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'Treatment of manifestations: All fevers and infections require prompt evaluation
      and treatment.'
    explanation: States the management principle for febrile episodes.
- name: Dental Hygiene and Periodontal Maintenance
  therapeutic_modality: BEHAVIORAL
  description: >-
    Good dental hygiene with regular periodontal maintenance, alongside G-CSF. It
    is listed here rather than folded into supportive care because periodontitis
    and gingivitis are modelled as phenotypes of this disease, and this is the
    intervention that addresses them.
  target_mechanisms:
  - target: Recurrent Infection and Mucosal Inflammation
    treatment_effect: INHIBITS
    description: Reduces the oral bacterial burden that the neutropenic windows would otherwise
      allow to produce gingival and periodontal destruction.
    evidence:
    - reference: PMID:23855177
      reference_title: Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: During a 2-year follow-up, his symptoms were well controlled by regular
        administration of granulocyte colony-stimulating factor and periodontal maintenance.
      explanation: Records periodontal maintenance as part of what controlled the oral
        manifestations, alongside G-CSF.
  evidence:
  - reference: PMID:20301705
    reference_title: ELANE-Related Neutropenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 'Prevention of secondary complications: Good dental hygiene; routine immunizations.'
    explanation: States dental hygiene as a recommended preventive measure in this condition.
animal_models:
- name: G193X Elane transgenic mouse
  species: Mouse
  genotype: G193X Elane
  publication: PMID:21285438
  description: >-
    A targeted Elane mutation reproducing a human severe congenital neutropenia
    allele. It is included here because of what it fails to do: the mice are not
    neutropenic, which is a real problem for the unfolded protein response model as
    a complete account.
  evidence:
  - reference: PMID:21285438
    reference_title: Activation of the unfolded protein response is associated with impaired granulopoiesis
      in transgenic mice expressing mutant Elane.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: 'To test this model, we generated transgenic mice carrying a targeted mutation of
      Elane (G193X) reproducing a mutation found in SCN.'
    explanation: Establishes the model and the human allele it reproduces.
  modeled_mechanisms:
  - target: Endoplasmic Reticulum Stress and Unfolded Protein Response
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    description: >-
      Granulocytic precursors carrying the mutation are selectively sensitive to
      endoplasmic reticulum stress, which supports the mechanism, but they show no
      basal unfolded protein response activation.
    limitations: >-
      The sensitivity is only revealed by chemical or proteasome-inhibitor
      challenge; unstressed animals look normal. The allele is also a severe
      congenital neutropenia allele rather than a cyclic one.
    evidence:
    - reference: PMID:21285438
      reference_title: Activation of the unfolded protein response is associated with impaired granulopoiesis
        in transgenic mice expressing mutant Elane.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: The selective sensitivity of G913X Elane granulocytic cells to ER stress provides
        new and strong support for the UPR model of disease patho-genesis in SCN.
      explanation: The authors' own summary of what the model does and does not establish. Note
        that the abstract itself contains a typographical error, writing G913X for G193X.
  - target: Apoptosis of Granulocytic Progenitors
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    description: >-
      The mice do not develop neutropenia. Basal and stress granulopoiesis are
      normal, so the model does not reproduce the ineffective granulopoiesis that
      defines the human disease.
    limitations: >-
      Recorded as a negative result rather than omitted, because a model that fails
      at the key phenotype constrains the mechanism more informatively than one
      that succeeds.
    evidence:
    - reference: PMID:21285438
      reference_title: Activation of the unfolded protein response is associated with impaired granulopoiesis
        in transgenic mice expressing mutant Elane.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: Granulocytic precursors from G193X Elane mice, though without significant basal
        UPR activation, are sensitive to chemical induction of ER stress. Basal and stress
        granulopoiesis after myeloablative therapy are normal in these mice.
      explanation: States directly that granulopoiesis is normal in these animals, which is the
        failure this link records.
- name: Grey Collie canine cyclic hematopoiesis
  species: Dog
  genotype: AP3B1 frameshift, homozygous
  publication: PMID:35904319
  description: >-
    The classical animal model, described in Grey Collies as the lethal grey
    syndrome. It reproduces the oscillation itself, on a twelve-day rather than a
    twenty-one-day cycle, and historically it shaped how the human disease was
    understood. It is genetically distinct: the canine disease is a recessive AP3B1
    defect, not an ELANE one.
  evidence:
  - reference: PMID:2979797
    reference_title: Pathobiology of canine cyclic hematopoiesis (review).
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Canine cyclic hematopoiesis (CH) was first described in Gray Collies as the lethal
      gray syndrome, and was subsequently shown to be a counterpart of human cyclic neutropenia
      (CN).
    explanation: Establishes the model and its relationship to the human disease.
  modeled_mechanisms:
  - target: Oscillatory Granulopoiesis
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      Reproduces a genuine cyclic oscillation of neutrophils originating in the
      bone marrow, confirmed by reciprocal bone marrow transplantation.
    limitations: >-
      Genetically distinct from the human disease: a homozygous recessive AP3B1
      frameshift rather than a heterozygous dominant ELANE mutation, with a twelve
      to fourteen day period rather than twenty-one, and a lethal course in the
      first months of life. It therefore models the oscillation as a phenomenon of
      marrow regulation, not the ELANE mechanism.
    evidence:
    - reference: PMID:2979797
      reference_title: Pathobiology of canine cyclic hematopoiesis (review).
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: Reciprocal bone marrow transplantation indicates that the defect resides in the
        bone marrow, but the actual site and mechanism of the defect has not been established.
      explanation: Localises the defect to the marrow, which is the feature shared with the human
        disease, while stating that the mechanism was unresolved.
    - reference: PMID:35904319
      reference_title: 'Cyclic hematopoiesis in a mixed-breed dog: case report and brief review.'
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: 'Genetic testing determined that the patient was homozygous mutant for the frameshift
        mutation in the adaptor protein complex 3 β-subunit (AP3B1) gene, originally identified
        in gray collies with cyclic hematopoiesis (CH).'
      explanation: Identifies the canine gene as AP3B1, which is the basis for the limitation
        recorded on this link.
references:
- reference: PMID:2979797
  title: "Pathobiology of canine cyclic hematopoiesis (review)."
- reference: PMID:11957190
  title: "Cyclic neutropenia."
- reference: PMID:20301705
  title: "ELANE-Related Neutropenia."
  tags:
  - GeneReviews
- reference: PMID:20582973
  title: "Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes."
- reference: PMID:21285438
  title: "Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane."
- reference: PMID:23463630
  title: "The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia."
- reference: PMID:23855177
  title: "Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis."
- reference: PMID:32083314
  title: "New insights into the pathomechanism of cyclic neutropenia."
- reference: PMID:32299910
  title: "Inducible expression of a disease-associated ELANE mutation impairs granulocytic differentiation, without eliciting an unfolded protein response."
- reference: PMID:35904319
  title: "Cyclic hematopoiesis in a mixed-breed dog: case report and brief review."
disease_term:
  preferred_term: cyclic hematopoiesis
  term:
    id: MONDO:0008090
    label: cyclic hematopoiesis
notes: >-
  Scope and naming. MONDO labels this entity cyclic hematopoiesis; the clinical
  literature almost always calls it cyclic neutropenia. Both are recorded, with
  the MONDO label as the disease_term and the clinical name as a synonym.

  Relationship to severe congenital neutropenia. The two are allelic and are best
  read as a spectrum rather than as separate diseases, on the evidence of a
  kindred in which one S97L allele on a shared paternal haplotype produced both
  phenotypes. They are nevertheless curated separately here, because the clinical
  consequence diverges completely at the point that matters most: severe
  congenital neutropenia carries a 15 to 25% risk of myelodysplasia or acute
  myeloid leukaemia after fifteen years of G-CSF, and cyclic neutropenia carries
  none. That divergence is recorded explicitly, under the Long-term outcome phase
  of progression, because the naive inference from a shared gene is wrong and
  worth contradicting rather than leaving to be inferred. It was initially modelled
  as a pathophysiology node; review round 1 was right that a negative clinical
  observation with no cell types, no processes and no edges is not a mechanism, and
  it renders as a floating node in the causal graph. The progression section is the
  correct home for it and the evidence moved intact.

  Mechanism confidence. The unfolded protein response model is well supported for
  this disease specifically, because PMID:32083314 measured it in patient CD34+
  cells at defined points in the cycle. It is not unchallenged. PMID:32299910 is
  recorded with supports REFUTE on that node: an inducible system showed impaired
  granulocytic differentiation without any unfolded protein response. That paper
  studied p.G185R, a severe congenital neutropenia allele, so it does not
  straightforwardly transfer, and the caveat is stated in the evidence
  explanation rather than left for a reader to notice. The G193X mouse is
  recorded with one FAILS_TO_RECAPITULATE link for the same reason: it does not
  become neutropenic, and that is more informative than omitting it.

  A quoting note. The snippet taken from PMID:21285438 reads "G913X" where the
  paper means G193X; the typographical error is in the source abstract. It is
  quoted verbatim because snippets must match the cached reference exactly, and
  the discrepancy is flagged in that evidence item's explanation.

  Ontology notes. HPO has an exact term for the defining phenotype
  (HP:0040289 Cyclically decreased total neutrophil count) and a child term that
  adds the marrow finding (HP:0410254), so both are used rather than a generic
  neutropenia parent. MAXO is not used in this repository, so treatments bind to
  NCIT actions with NCIT therapeutic agents; filgrastim has no CHEBI term.

  Known extension points: prevalence, for which no cleanly quotable figure was
  found in the cached abstracts; clinical_trials; the mathematical modelling
  literature on the oscillation, which is substantial and would justify a
  computational_models section; and stem cell transplantation, which is used in
  severe congenital neutropenia but is rarely indicated here and would need
  cyclic-specific evidence rather than borrowed evidence.

  Provenance. Curated directly from PubMed rather than from a deep-research
  report: both configured research providers remain unavailable
  (openscientist.io returns CloudFront 403 on POST and 401 on authenticated GET;
  the cyberian backend returns 500). Every snippet was fetched with
  just fetch-reference and verified as an exact substring of the cached abstract.
📚

References & Deep Research

References

10
Pathobiology of canine cyclic hematopoiesis (review).
No top-level findings curated for this source.
Cyclic neutropenia.
No top-level findings curated for this source.
ELANE-Related Neutropenia.
No top-level findings curated for this source.
Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes.
No top-level findings curated for this source.
Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane.
No top-level findings curated for this source.
The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.
No top-level findings curated for this source.
Cyclic neutropenia presenting as recurrent oral ulcers and periodontitis.
No top-level findings curated for this source.
New insights into the pathomechanism of cyclic neutropenia.
No top-level findings curated for this source.
Inducible expression of a disease-associated ELANE mutation impairs granulocytic differentiation, without eliciting an unfolded protein response.
No top-level findings curated for this source.
Cyclic hematopoiesis in a mixed-breed dog: case report and brief review.
No top-level findings curated for this source.